5/18
Health Sciences
A hopeful time for Cryptosporidium research
A hopeful time for Cryptosporidium research
Boris Striepen of Penn Vet organized the First Biennial Cryptosporidium Meeting, bringing together researchers and clinicians from around the world to discuss the problems and progress around the parasite and the diarrheal disease it causes.
A novel technique to form human artificial chromosomes
A novel technique to form human artificial chromosomes
Penn researchers say the new technique for making human artificial chromosomes from single, long constructs of designer DNA will allow for more efficient laboratory research.
Adding diversity to your research process: A new system
Adding diversity to your research process: A new system
A Penn team has created guidelines and a best practices overview for incorporating equity and diversity into the research process.
‘Welcome to your future’: Penn celebrates Match Day 2024
‘Welcome to your future’: Penn celebrates Match Day 2024
On the third Friday of March, Perelman School of Medicine’s class of 2024 celebrated their future residencies.
‘Can Technology Spark Joy and Imagination?’
‘Can Technology Spark Joy and Imagination?’
In the 2024 Albert M. Greenfield Memorial lecture hosted by Penn Nursing, Desmond Upton Patton and Courtney D. Cogburn discussed how social media and AI might foster well-being.
A humanities pathway to pre-med
A humanities pathway to pre-med
Pre-med students majoring in English, theatre, history, and other humanities fields find satisfaction in tapping into multiple interests—and see benefits for a career in medicine.
2023 PIP/PEP winners: Where are they now?
2023 PIP/PEP winners: Where are they now?
Nearly a year after the winners of the President’s Innovation Prize (PIP) and President’s Engagement Prize (PEP) began their projects, the winners—now alumni—discuss their progress.
Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants
Initial SARS-CoV-2 vaccinations prime immune cells to respond to subsequent variants
Immunological imprinting from the original ancestral SARS-CoV-2 strain has a significant impact on the antibody responses to the variants and boosters based on them.
Mapping pancreatic cancer to improve immunotherapy
Mapping pancreatic cancer to improve immunotherapy
Gregory L. Beatty, an associate professor of hematology-oncology and member of Penn Medicine’s Abramson Cancer Center, and his team focus on improving immunotherapy for pancreatic cancer.
‘Dual target’ cell therapy appears to shrink brain tumors
‘Dual target’ cell therapy appears to shrink brain tumors
Early Penn Medicine trial results show that targeting two tumor-associated proteins in patients with recurrent glioblastoma may be a promising step toward developing cell therapies for solid tumors.
In the News
Slate.com
What’s going on with tranq?
Jeanmarie Perron of the Perelman School of Medicine says that the appearance and progression of skin ulcers and tissue loss on xylazine users is different than with other intravenous drugs.
FULL STORY →
The Hill
It’s time to end the Medicare-Medicaid merry-go-round
In an opinion essay, Rachel M. Werner of the Leonard Davis Institute, Wharton School, and Perelman School of Medicine says that Medicare and Medicaid fail to integrate coverage and coordinate care across their two plans.
FULL STORY →
The Wall Street Journal
The quest for treatments to keep weight off after Ozempic
Researchers at Penn are conducting a co-authored study of the brains, fat and muscle cells, and eating patterns of people trying to maintain new body sizes.
FULL STORY →
Philadelphia Inquirer
Inside Penn’s transfer center
Penn Medicine’s transfer command center gets patients from affiliated hospitals and hospitals outside Philadelphia to specialized care that can save lives, with comments from CEO Kevin Mahoney.
FULL STORY →
Philadelphia Inquirer
Operating rooms are major sources of greenhouse gasses. Penn is eliminating a form of anesthesia that hangs in the air for more than a decade after use
Penn Medicine is phasing out the anesthesia desflurane at four of its six hospitals to eliminate harmful greenhouse gases, with remarks from Greg Evans.
FULL STORY →